MeSH tree: C18.654
New research from the Guelph Family Health Study (GFHS) has found that circadian rhythm-related genes could influence the risk of obesity in children, highlighting an important connection between sleep and eating behavior.
Jul 28, 2026
0
4
Ever wonder why some people crave sweets while others can take them or leave them? Preliminary findings from a new study suggest that people who carry certain genetic variants associated with a preference for sweet or fatty ...
Jul 27, 2026
0
3
Childhood obesity affects 1 in 5 children in the U.S., yet most families have limited access to specialized weight-management programs for children. Now, a large clinical trial led by researchers at Washington University ...
Jul 27, 2026
0
3
Noncommunicable diseases—heart disease, stroke, diabetes, cancer—are no longer just a rich-country problem. Across Africa, they are becoming the leading cause of death, driven in part by a simple and overlooked culprit: what ...
Jul 26, 2026
0
7
Researchers have identified a biological marker that rises and falls as body fat changes, offering new insight into how weight gain and weight loss may influence metabolic health.
Jul 24, 2026
0
3
In a recent study published in Nature Communications, researchers from the University of Colorado Anschutz Linda Crnic Institute for Down Syndrome (Crnic Institute) discovered unique biological processes altered among individuals ...
Jul 23, 2026
0
9
Young women are leading a worrying increase in early-onset type 2 diabetes diagnoses in England, according to a new analysis. In a population study of type 2 diabetes in England, researchers found a clear generational divide, ...
Jul 22, 2026
0
5
Hispanic and Asian adults with longer durations of U.S. residence have a higher prevalence of obesity, according to a research letter published in the Annals of Internal Medicine.
Jul 22, 2026
0
4
Women with polyendocrine metabolic ovarian syndrome (PMOS; also known as polycystic ovary syndrome or PCOS) face a fourfold higher risk of heart disease than women without PMOS, according to a new nationwide U.S. study published ...
Jul 21, 2026
0
9
Use of newer GLP-1 receptor agonists (semaglutide or tirzepatide) for obesity or diabetes among people with alcohol use disorder was associated with a reduction in alcohol-related hospital admissions, according to a study ...
Jul 21, 2026
0
6
